Annals of Neurology · 1993 · 60 citations · 15 references
Life SciencesBiochemistryNeuroscienceNeurodegenerationNeuropharmacologyProtein FoldingAlzheimer DiseaseAmyloid FormationNeurodegenerative DiseasesNeurodegenerative DisordersProtein AggregationProtein Aggregation DisordersAmyloid Beta AggregationAmyloid Beta PeptidesAmyloid Fibril FormationAmyloid Fibril StructureAmyloid FibrillogenesisAmyloid FibrilsAmyloid PlaquesAmyloid Structure
Alzheimer's disease is characterized by the deposition of beta-protein (A beta) as amyloid. Recently, it was found that A beta is a normal component of serum and cerebrospinal fluid. Synthetic peptides homologous to A beta form amyloid-like fibrils spontaneously in water or physiological solutions. Using a peptide homologous to A beta 1-40, we find that fibril formation is inhibited by the presence of cerebrospinal fluid.
15
Warren J. Strittmatter, Ann M. Saunders, D. E. Schmechel et al. · Proceedings of the National Academy of Sciences · 1993 · 4.3K citations · Full text
Life Sciences, Genetics, Neurology +17
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Peter Seubert, Carmen Vigo‐Pelfrey, Fred Esch et al. · Nature · 1992 · 1.7K citations
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Mikio Shoji, Todd E. Golde, Jorge Ghiso et al. · Science · 1992 · 1.4K citations